Quality of Life Analysis of Treatment in Patients With Prostate Cancer on Adjuvant Zoladex Therapy
NCT ID: NCT00692874
Last Updated: 2010-12-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1646 participants
OBSERVATIONAL
2008-06-30
2010-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Early or locally-advanced prostate cancer patients on androgen deprivation therapy
* Investigators are requested to recruit patients only with at least 1 month prior Zoladex treatment.
Exclusion Criteria
* Prostate cancer patients with advanced disease
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AstraZeneca
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Péter Tenke, M.D.
Role: PRINCIPAL_INVESTIGATOR
"Jahn Ferenc" City Hospital Budapest
Csaba Csongvai
Role: STUDY_DIRECTOR
AstraZeneca Hungary
Éva Gulyás
Role: STUDY_CHAIR
AstraZeneca Hungary
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Baja, , Hungary
Research Site
Békés, , Hungary
Research Site
Békéscsaba, , Hungary
Research Site
Budapest, , Hungary
Research Site
Cegléd, , Hungary
Research Site
Dunaújváros, , Hungary
Research Site
Érd, , Hungary
Research Site
Győr, , Hungary
Research Site
Gyula, , Hungary
Research Site
Kiskunhalas, , Hungary
Research Site
Nagykőrös, , Hungary
Research Site
Nyíregyháza, , Hungary
Research Site
Pécs, , Hungary
Research Site
Sopron, , Hungary
Research Site
Szeged, , Hungary
Research Site
Szentendre, , Hungary
Research Site
Székesfehérvár, , Hungary
Research Site
Tatabánya, , Hungary
Research Site
Vác, , Hungary
Research Site
Zalaegerszeg, , Hungary
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-OHU-ZOL-2007/1
Identifier Type: -
Identifier Source: org_study_id